```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3926 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 3926

   To direct the Secretary of Defense and the Secretary of Veterans 
 Affairs to jointly conduct a study on the incidence of breast cancer 
            among members of the Armed Forces and veterans.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 26, 2009

Mr. Boswell (for himself, Mr. Walz, Mr. Hall of New York, Mr. LoBiondo, 
 Mrs. Dahlkemper, Mr. Braley of Iowa, and Mr. Loebsack) introduced the 
following bill; which was referred to the Committee on Armed Services, 
and in addition to the Committee on Veterans' Affairs, for a period to 
      be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
   To direct the Secretary of Defense and the Secretary of Veterans 
 Affairs to jointly conduct a study on the incidence of breast cancer 
            among members of the Armed Forces and veterans.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Armed Forces Breast Cancer Research 
Act''.

SEC. 2. STUDY ON BREAST CANCER AMONG MEMBERS OF THE ARMED FORCES AND 
              VETERANS.

    (a) Study.--The Secretary of Defense and the Secretary of Veterans 
Affairs shall jointly conduct a study on the incidence of breast cancer 
among members of the Armed Forces (including members of the National 
Guard and Reserve components) and veterans. Such study shall include 
the following:
            (1) A determination of the number of the members and 
        veterans diagnosed with breast cancer.
            (2) A determination of demographic information regarding 
        such members and veterans, including--
                    (A) race;
                    (B) ethnicity;
                    (C) sex;
                    (D) age;
                    (E) possible exposure to hazardous elements or 
                chemical or biological agents (including any vaccines) 
                and where such exposure occurred;
                    (F) the locations of duty stations that such member 
                or veteran was assigned;
                    (G) the locations in which such member or veteran 
                was deployed; and
                    (H) the geographic area of residence prior to 
                deployment.
            (3) An analysis of breast cancer treatments received by 
        such members and veterans.
            (4) Other information the Secretaries consider necessary.
    (b) Report.--Not later than 18 months after the date of the 
enactment of this Act, the Secretary of Defense and the Secretary of 
Veterans Affairs shall jointly submit to Congress a report containing 
the results of the study required under subsection (a).
                                 <all>
```